Sangamo Therapeutics SGMOQ
OTC SGMOQ
$0.11 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

Sangamo Therapeutics (SGMOQ) FCF Margin (2009 - 2026)

Updated

Sangamo Therapeutics' FCF Margin came in at -1338.07% for Q1 2026, down 931.84 percentage points from -406.23% a year earlier and down 1166.46 percentage points from the prior quarter.

Analysis

Sangamo Therapeutics (SGMOQ) FCF Margin (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Mar 31, 2026, Sangamo Therapeutics reported FCF Margin of -261.76%, down 191.35 percentage points year-over-year; for FY2025, it was -246.03%, down 129.41 percentage points from FY2024.

  • FCF Margin carries a five-year change of -377.31 percentage points (FY2020 to FY2025).
  • Going back by year, FCF Margin was -116.62% in FY2024 (+22.97 pp), -139.59% in FY2023 (+79.46 pp), -219.05% in FY2022 (+12.68 pp) and -231.73% in FY2021 (-363.01 pp).
  • The five-year range for quarterly FCF Margin is -10117.05% (Q1 2024) to 23.57% (Q3 2024).
  • Year-over-year, FCF Margin has declined for three consecutive quarters, with an average year-over-year change of +962.43 percentage points over the last eight quarters.
  • The fastest year-over-year change in FCF Margin over five years came in Q1 2025 (a gain of 9710.82 percentage points), and the weakest in Q1 2024 (a drop of 10068.62 percentage points).
  • Business Quant data shows SGMOQ's FCF Margin at -171.61% (Q4 2025), -4916.01% (Q3 2025) and -99.32% (Q2 2025) in the three quarters before Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 33.69%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 25.03%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 41.97%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.51%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 52.85%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.25%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 57.81%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 28.96%
10 Sangamo Therapeutics 45.57 Mn -70.94 Mn - -1,338.07%
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,338.07%
Dec 31, 2025 -171.61%
Sep 30, 2025 -4,916.01%
Jun 30, 2025 -99.32%
Mar 31, 2025 -406.23%
Dec 31, 2024 -46.39%
Sep 30, 2024 23.57%
Jun 30, 2024 -7,551.69%
Mar 31, 2024 -10,117.05%
Dec 31, 2023 -2,605.73%
Sep 30, 2023 -532.42%
Jun 30, 2023 -969.29%
Mar 31, 2023 -48.43%
Dec 31, 2022 -236.96%
Sep 30, 2022 -219.32%
Jun 30, 2022 -202.29%
Mar 31, 2022 -218.96%
Dec 31, 2021 -198.57%
Sep 30, 2021 -226.26%
Jun 30, 2021 -214.66%
API Access

Sangamo Therapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY